Hyundai Hope on Wheels Presents CHOP with $500,000 Grant
Sep 28, 2018
Hyundai Hope on Wheels Awards CHOP with Hyundai Hope Scholar and Young Investigator Grant to support pediatric cancer research.
Your child will be cared for by one of the most accomplished teams of childhood cancer experts in the world. We provide medical care, emotional counseling and much more. We make sure your child, you and every family member get the highest level of support.
Sep 28, 2018
Hyundai Hope on Wheels Awards CHOP with Hyundai Hope Scholar and Young Investigator Grant to support pediatric cancer research.
Sep 17, 2018
CHOP patient family credits faith and doctors for recovery and donates $50,000 to Children's Hospital of Philadelphia.
Sep 10, 2018
The new research platform will make large-scale data on childhood cancer and birth defects available to researchers, clinicians and patients within a cloud-based environment.
Sep 5, 2018
Children’s Hospital of Philadelphia was recognized specifically for significant contributions to the development of a new treatment for a certain pediatric leukemia.
Aug 24, 2018
The European Commission (EC) approves Kymriah, the first-ever U.S. FDA approved personalized CAR T-cell gene immunotherapy for aggressive blood cancers.
May 15, 2017
A leading pediatric oncologist at CHOP, Dr. Grupp is now Chief of the Section of Cellular Therapy and Transplant in the Hospital’s Division of Oncology.
Jul 24, 2018
Too much sun can cause sunburn and, over time, skin cancer. Know the risks of skin cancer and how to spend time outside safely.
Jun 25, 2018
The award supports accomplished leaders in oncology research who make significant contributions toward the understanding and treatment of cancer.
Apr 25, 2018
Dr. Grupp focuses on required preparations, recovery phase, and potential new applications of CAR T-cell therapy.
May 9, 2018
The Templeton family's $3 million gift to CHOP will support the Philadelphia Coalition for a Cure, a brain tumor initiative led by CHOP’s Center for Data-Driven Discovery in Biomedicine.